PlantForm has also received funding from the federal government for development of a plant-made version of an enzyme that counteracts the effects of nerve agents such as sarin, the release said. “We believe that plants hold the key to cost-effective, large-scale production of antidotes for ricin and other potential bioterrorism threats.”
“We’re very encouraged by the initial study results for the plant-produced anti-ricin antibody, and we look forward to the next phase of evaluation,” PlantForm president and CEO Don Stewart said in the release. Hall is PlantForm’s co-founder and its chief scientific officer.ĭefence Research and Development Canada studies have found the plant-made version of the antibody showed effectiveness against ricin exposure was comparable to the effectiveness of hD9 produced using mammalian cell technology, the release said. Christopher Hall to evaluate the potential for PlantForm’s tobacco-plant-based drug expression system to produce the hD9 antibody. The contract to PlantForm follows work conducted last year in the lab of University of Guelph Professor Emeritus J.
0 kommentar(er)
